How long is a course of treatment for Silibinin Glucuronamide Tablets?

　　The conventional treatment course for Silibinin Meglumine Tablets lasts 1 to 3 months, with the specific duration adjusted according to therapeutic goals. A longer course is recommended when used for repairing chronic liver damage, while a shorter duration may be sufficient when used to assist in improving abnormal liver function. If symptoms do not improve or adverse reactions occur during treatment, prompt medical consultation is advised.

　　This medication is primarily used to protect liver cells and improve liver metabolism, serving as an adjunctive treatment for chronic hepatitis, fatty liver, and other liver diseases. Liver repair takes time, and short-term use is unlikely to achieve optimal results; completing the full course ensures sustained hepatoprotective effects.

　　For patients with mild conditions and slight abnormalities in liver function tests, a treatment course of 1–2 months is generally sufficient to improve symptoms. For those with more severe disease and evident liver damage, the course should extend to 3 months; some patients may require multiple courses based on their recovery progress to ensure gradual and stable restoration of liver function.

　　During treatment, maintain a light diet, avoid greasy, spicy foods and alcohol to reduce the burden on the liver; adhere to regular sleep patterns and avoid staying up late; engage in moderate, gentle exercise; and undergo regular liver function check-ups. Follow medical advice to adjust the treatment course based on test results, ensuring both efficacy and safety.